Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria.
ABSTRACT To evaluate, by using electrocardiographically (ECG)-gated multidetector computed tomography (CT), parameters such as right ventricular outflow tract (RVOT) systolic shortening and myocardial thickness and right pulmonary artery (RPA) distensibility, reported to be abnormal at echocardiography and/or magnetic resonance (MR) imaging in patients with pulmonary hypertension (PHT).
The institutional review board approved the study and waived informed consent. Forty-five patients, 21 with PHT (group 1; mean pulmonary arterial pressure [PAP], 42 mm Hg) and 24 without (group 2; mean PAP, 16.5 mm Hg), who had undergone thoracic ECG-gated 64-section CT and right heart catheterization as part of their diagnostic work-up were included in this study. Two independent observers measured RPA distensibility and RVOT myocardial thickness, diameter, and cross-sectional area during systole and diastole. Their values were compared in both groups (Mann-Whitney U test). The area under the receiver operating characteristic (ROC) curve and Spearman correlation with mean PAP were also obtained.
Interobserver agreement was good for all measurements (R > 0.8) except for systolic RVOT wall thickness. Median values of RPA distensibility, diastolic RVOT wall thickness, and systolic RVOT diameter and cross-sectional area were significantly different between groups 1 and 2. The largest area under the ROC curve was obtained with RPA distensibility (0.951; 95% confidence interval: 0.89, 1) also showing the closest correlation with mean PAP (r = -0.79; P < .0001).
Among all parameters evaluated, RPA distensibility shows the best diagnostic value for PHT and could be useful for risk stratification.
- [show abstract] [hide abstract]
ABSTRACT: To establish the value of the main pulmonary artery (MPA) diameter assessed from unenhanced computer tomography (CT) scans used for attenuation correction (AC) of single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) to predict pulmonary hypertension (PHT). In contrast-enhanced chest CT scans an MPA diameter of 29 mm or greater is an established predictor of PHT. However, it is unknown, whether measurements from an unenhanced CT scan for AC may be used as predictor of PHT. 100 patients underwent SPECT MPI for assessment of coronary artery disease. PHT was defined as a right ventriculo-atrial gradient of 30 mm Hg or greater by Doppler echocardiography. We compared MPA diameter from CT to SPECT findings (right ventricular hypertrophy/enlargement, septal wall motion abnormality/perfusion defect, and D-shape) to determine the best predictor of PHT. PHT was found in 37 patients. An MPA diameter of 30 mm or greater yielded a sensitivity, specificity, accuracy, positive, and negative predictive value of 78%, 91%, 86%, 83%, and 88%, respectively. This yielded an area under the ROC curve of 0.85. MPA diameter from low-dose unenhanced multi-slice CT reliably predicts PHT, providing an important added clinical value from AC for SPECT MPI.Journal of Nuclear Cardiology 06/2011; 18(4):634-41. · 2.85 Impact Factor
- [show abstract] [hide abstract]
ABSTRACT: The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an increase in pulmonary vascular resistance, right heart failure and death. Its etiology may be idiopathic, but PAH is also frequently associated with underlying conditions such as connective tissue diseases. During the past decade, more than welcome novel therapies have been developed and are in development, including those increasingly targeting the remodeling process. These therapeutic options modestly increase the patients' long-term survival, now approaching 60% at 5 years. However, non-invasive tools for confirming PAH diagnosis, and assessing disease severity and response to therapy, are tragically lacking and would help to select the best treatment. After exclusion of other causes of pulmonary hypertension, a final diagnosis still relies on right heart catheterization, an invasive technique which cannot be repeated as often as an optimal follow-up might require. Similarly, other techniques and biomarkers used for assessing disease severity and response to treatment generally lack specificity and have significant limitations. In this review, imaging as well as current and future circulating biomarkers for diagnosis, prognosis, and follow-up are discussed.Cellular and Molecular Life Sciences CMLS 03/2012; 69(17):2805-31. · 5.62 Impact Factor
Article: Right heart on multidetector CT.[show abstract] [hide abstract]
ABSTRACT: Right ventricular function plays an integral role in the pathogenesis and outcome of many cardiovascular diseases. Imaging the right ventricle has long been a challenge because of its complex geometry. In recent years there has been a tremendous expansion in multidetector row CT (MDCT) and its cardiac applications. By judicious modification of contrast medium protocol, it is possible to achieve good opacification of the right-sided cardiac chambers, thereby paving the way for exploring the overshadowed right heart. This article will describe the key features of right heart anatomy, review MDCT acquisition techniques, elaborate the various morphological and functional information that can be obtained, and illustrate some important clinical conditions associated with an abnormal right heart.The British journal of radiology 12/2011; 84 Spec No 3:S306-23. · 2.11 Impact Factor